The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer.

bariatric surgery cancer endometrial cancer malignancy metabolic surgery obesity

Journal

Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127

Informations de publication

Date de publication:
2022
Historique:
received: 13 05 2022
accepted: 25 07 2022
entrez: 19 9 2022
pubmed: 20 9 2022
medline: 20 9 2022
Statut: epublish

Résumé

The obesity pandemic continues to contribute to a worsening burden of disease worldwide. The link between obesity and diseases such as diabetes, cardiovascular disease, and cancer has been well established, yet most patients living with obesity remain untreated or undertreated. Metabolic and bariatric surgery is the most effective and durable treatment for obesity, is safe, and may have a protective benefit with respect to cancer incidence. In this review, an overview of the link between obesity, metabolic surgery, and cancer is discussed with emphasis on indications for endometrial cancer, the malignancy most strongly associated with obesity. Considerable evidence from retrospective and prospective cohort studies supports a decreased risk of endometrial cancer in patients with obesity who undergo bariatric surgery compared with nonsurgical controls. Survivors of endometrial cancer are at increased risk of poor health outcomes associated with obesity, and women with endometrial cancer are more likely to die of cardiovascular disease and other obesity-related illnesses than of the malignancy itself. Recent advances in anticancer drug therapies have targeted pathways that may also be therapeutically altered with metabolic surgery. Metabolic surgery has significant potential to enter the treatment paradigm for endometrial cancer, and gynecologic oncologist visits present an opportunity to identify patients who may benefit the most.

Identifiants

pubmed: 36117808
doi: 10.3389/fsurg.2022.943544
pmc: PMC9470773
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

943544

Subventions

Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States

Informations de copyright

© 2022 Ross, Akinde, Schauer, le Roux, Brennan, Jernigan, Bueter and Albaugh.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Metab. 2017 Jan 13;5:1
pubmed: 28101337
J Urol. 2013 Nov;190(5):1657-61
pubmed: 23665301
J Gastroenterol Hepatol. 2021 Oct;36(10):2834-2840
pubmed: 34033134
Nutrition. 2018 Oct;54:94-99
pubmed: 29778908
JAMA. 2019 Oct 01;322(13):1271-1282
pubmed: 31475297
Obes Surg. 2020 Apr;30(4):1265-1272
pubmed: 31865552
Am J Surg. 2021 Oct;222(4):715-722
pubmed: 33771341
Am J Transplant. 2021 Apr;21(4):1525-1534
pubmed: 32976702
Public Health Rep. 2019 Mar/Apr;134(2):141-149
pubmed: 30794761
Int J Mol Sci. 2022 Feb 25;23(5):
pubmed: 35269674
Obes Surg. 2019 Apr;29(4):1122-1129
pubmed: 30723879
Obes Surg. 2016 Nov;26(11):2590-2601
pubmed: 26992897
JAMA. 2006 Jul 12;296(2):193-201
pubmed: 16835425
Obes Surg. 2014 Sep;24(9):1499-509
pubmed: 24817500
Pancreatology. 2019 Oct;19(7):941-950
pubmed: 31447281
J Neuroendocrinol. 2019 May;31(5):e12708
pubmed: 30882956
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
Adv Nutr. 2016 Jan 15;7(1):66-75
pubmed: 26773015
JCI Insight. 2021 Apr 22;6(8):
pubmed: 33724954
J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):906-9
pubmed: 25843520
Ann Surg. 2019 Jan;269(1):95-101
pubmed: 28938270
Front Endocrinol (Lausanne). 2019 Sep 19;10:626
pubmed: 31608009
Chirurgia (Bucur). 2019 Nov-Dec;114(6):704-710
pubmed: 31928575
N Engl J Med. 2014 May 22;370(21):2002-13
pubmed: 24679060
Br J Surg. 2020 Mar;107(4):348-354
pubmed: 31976551
Pancreas. 2018 Feb;47(2):158-162
pubmed: 29346216
Ann Surg. 2021 Sep 1;274(3):524-532
pubmed: 34132694
N Engl J Med. 2020 Oct 15;383(16):1535-1543
pubmed: 33053284
Lancet Oncol. 2002 Sep;3(9):565-74
pubmed: 12217794
Lancet Diabetes Endocrinol. 2015 Nov;3(11):847-54
pubmed: 26429401
Front Immunol. 2016 Jan 05;6:637
pubmed: 26779183
Lancet. 2021 May 15;397(10287):1830-1841
pubmed: 33965067
Am J Obstet Gynecol. 2013 May;208(5):408.e1-8
pubmed: 23395643
Curr Obes Rep. 2020 Jun;9(2):159-164
pubmed: 32253662
Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:220-226
pubmed: 27773356
Gynecol Oncol. 2012 Aug;126(2):176-9
pubmed: 22507532
Epidemiol Health. 2020;42:e2020004
pubmed: 32023777
Int J Obes (Lond). 2019 Nov;43(11):2189-2199
pubmed: 30979972
BMJ. 2013 Oct 22;347:f5934
pubmed: 24149519
Int J Mol Sci. 2019 May 28;20(11):
pubmed: 31141984
JAMA. 2018 Oct 16;320(15):1570-1582
pubmed: 30326126
PLoS Med. 2020 Jul 28;17(7):e1003206
pubmed: 32722673
Lancet Public Health. 2018 Oct;3(10):e490-e497
pubmed: 30177479
J Exp Med. 2022 Mar 7;219(3):
pubmed: 35103755
Biomolecules. 2021 Oct 26;11(11):
pubmed: 34827579
Clin Cancer Res. 2020 Feb 1;26(3):581-587
pubmed: 31628143
JAMA. 2018 Jan 16;319(3):279-290
pubmed: 29340677
N Engl J Med. 2022 Feb 3;386(5):437-448
pubmed: 35045221
Obes Surg. 2020 Sep;30(9):3417-3425
pubmed: 32307670
Br J Surg. 2018 Nov;105(12):1650-1657
pubmed: 30003539
Obstet Gynecol. 2019 Sep;134(3):570-572
pubmed: 31403586
Crit Rev Oncol Hematol. 2017 Mar;111:1-6
pubmed: 28259284
Diabetes Obes Metab. 2015 Feb;17(2):198-201
pubmed: 25352176
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
JAMA Dermatol. 2020 Jan 1;156(1):38-43
pubmed: 31664428
Nat Rev Cancer. 2012 Feb 16;12(3):159-69
pubmed: 22337149
Cancer Sci. 2010 May;101(5):1073-9
pubmed: 20345478
J Clin Oncol. 2015 Mar 10;33(8):930-6
pubmed: 25624430
J Clin Oncol. 2022 Mar 1;40(7):752-761
pubmed: 34990208
BMJ Case Rep. 2021 Jul 22;14(7):
pubmed: 34301707
Obes Surg. 2017 Nov;27(11):3014-3020
pubmed: 28840450
JAMA Pediatr. 2014 Jan;168(1):47-53
pubmed: 24189578
JAMA. 2020 Sep 1;324(9):879-887
pubmed: 32870301
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
Surgery. 2021 Jul;170(1):13-17
pubmed: 33714616
Oxid Med Cell Longev. 2019 Dec 6;2019:3940739
pubmed: 31885787
Eur Urol. 2019 Jan;75(1):74-84
pubmed: 30243799
Surg Obes Relat Dis. 2020 Oct;16(10):1596-1602
pubmed: 32690459
Diabetes Care. 2022 Feb 1;45(2):444-450
pubmed: 34799430
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):949-55
pubmed: 25620433
J Minim Invasive Gynecol. 2015 Jan;22(1):94-102
pubmed: 25064420
Ann Intern Med. 2018 Dec 4;169(11):741-750
pubmed: 30383139
Obesity (Silver Spring). 2020 Dec;28(12):2290-2304
pubmed: 33230959
Curr Oncol Rep. 2018 Apr 11;20(6):47
pubmed: 29644507
J Immunol. 2012 Feb 15;188(4):1933-41
pubmed: 22246631
Obes Surg. 2018 May;28(5):1433-1440
pubmed: 29512036
Endocrinology. 2018 Nov 1;159(11):3801-3812
pubmed: 30215698
BJOG. 2013 Jun;120(7):795-800
pubmed: 23231632
Am J Obstet Gynecol. 2015 Sep;213(3):350.e1-10
pubmed: 25981846
Clin J Gastroenterol. 2019 Aug;12(4):285-291
pubmed: 30788774
Surgery. 2021 Sep;170(3):659-663
pubmed: 34052027
Cell Metab. 2015 Mar 3;21(3):369-78
pubmed: 25662404
Surg Endosc. 2013 Dec;27(12):4449-56
pubmed: 23949484
Int J Obes (Lond). 2019 Jun;43(6):1147-1153
pubmed: 30470806
J Clin Oncol. 2016 Dec 10;34(35):4225-4230
pubmed: 27903150
N Engl J Med. 2009 Jul 30;361(5):445-54
pubmed: 19641201
Lancet Oncol. 2018 Mar;19(3):310-322
pubmed: 29449192
Gastroenterology. 2021 Jul;161(1):171-184.e10
pubmed: 33744305
World J Diabetes. 2012 Apr 15;3(4):71-9
pubmed: 22532886
Eur Heart J. 2020 Jul 21;41(28):2660-2667
pubmed: 32188981
Obstet Gynecol. 2015 Jan;125(1):274-278
pubmed: 25560144
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Cancer Biol Med. 2019 Feb;16(1):55-70
pubmed: 31119046
Gynecol Oncol. 2014 Sep;134(3):540-5
pubmed: 24933102
Lancet Oncol. 2015 Jan;16(1):36-46
pubmed: 25467404
Curr Opin Urol. 2017 Sep;27(5):409-414
pubmed: 28650865
Obes Surg. 2019 Mar;29(3):1031-1039
pubmed: 30591985
Am J Transl Res. 2018 Nov 15;10(11):3713-3722
pubmed: 30662621
BMC Med. 2020 Dec 17;18(1):396
pubmed: 33327948
JAMA. 2022 Jun 28;327(24):2423-2433
pubmed: 35657620
JAMA Surg. 2020 May 1;155(5):395-402
pubmed: 32159744
Int J Cancer. 2020 Aug 1;147(3):728-735
pubmed: 31797382
Cancer Causes Control. 2012 May;23(5):717-26
pubmed: 22450736
PLoS One. 2021 Mar 25;16(3):e0248550
pubmed: 33764991
Biogerontology. 2016 Feb;17(1):7-19
pubmed: 25921609

Auteurs

Robert C Ross (RC)

Translational and Integrative Gastrointestinal and Endocrine Research Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, United States.

Yetunde M Akinde (YM)

Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.

Philip R Schauer (PR)

Metamor Institute, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, United States.

Carel W le Roux (CW)

School of Medicine, St. Vincent's University Hospital and University College Dublin, Dublin, Ireland.

Donal Brennan (D)

UCD Gynecological Oncology Group, UCD School of Medicine, Catherine McAuley Research Centre, Mater Misericordiae University Hospital, Belfield, Dublin, Ireland.

Amelia M Jernigan (AM)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.

Marco Bueter (M)

Department of Visceral and Transplantation Surgery, University Hospital of Zürich, Zürich, Switzerland.

Vance L Albaugh (VL)

Translational and Integrative Gastrointestinal and Endocrine Research Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, United States.
Metamor Institute, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, United States.

Classifications MeSH